3//SEC Filing
Motif Pharmaceuticals Ltd. 3
Accession 0001753926-24-000330
CIK 0001919246other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 8:36 PM ET
Size
15.7 KB
Accession
0001753926-24-000330
Insider Transaction Report
Form 3
Motif Pharmaceuticals Ltd.
10% Owner
Holdings
- 470,674
Common Stock
Senior Secured Convertible Promissory Note
Exp: 2024-02-29→ Common Stock (12,732 underlying)
Footnotes (2)
- [F1]Represents $61,109.98 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due February 29, 2024, which will automatically convert into 12,732 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering.
- [F2]Zachary Klein has sole voting and dispositive power over the shares held by the Reporting Person as to which Mr. Klein disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Documents
Issuer
Chromocell Therapeutics Corp
CIK 0001919246
Entity typeother
IncorporatedIreland
Related Parties
1- filerCIK 0001988875
Filing Metadata
- Form type
- 3
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 8:36 PM ET
- Size
- 15.7 KB